Original Research

An Ounce of Prevention Is Not a Choice a Patient Gets to Make for Late-Stage Cancer
Generic Imatinib: Can It Provide Significant Cost Relief for Patients?
Response-Guided Therapy an Appropriate Tool for Evaluating Treatment Protocols and Costs of Drug Therapies
Employers’ Obesity Initiatives in the Workplace: A Wakeup Call for Health Plans
Benefit Management Considerations for BPH Medications: Single Agent or Combination Therapy?
A Collaborative Approach to Drug Selection, Driven by Clinical Outcomes Excellence
Page 6 of 7
Results 51 - 60 of 65
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME